Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5076122 | 1.00 | GLO1 (0.47) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL27570223 | 0.85 | GLO1 (0.45) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL17531543 | 0.84 | NPSR1 (0.41) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL3289816 | 0.83 | GLO1 (0.44) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL29100689 | 0.82 | GLO1 (0.47) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL17531544 | 0.81 | NPSR1 (0.39) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL1063229 | 0.80 | GLO1 (0.41) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL22716051 | 0.80 | GLO1 (0.41) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL22716716 | 0.80 | GLO1 (0.41) | GLO1ALDH1A1LMNAHSD17B10NPSR1 | |
| SCHEMBL14211015 | 0.80 | GLO1 (0.41) | GLO1ALDH1A1LMNAHSD17B10NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0838215-B1 | Use of unsaturated aliphatic esters in perfumery | FIRMENICH & CIE (CH) | 2004-04-28 | — | — | EP | claimed |
| US-5814598-A | Use of unsaturated aliphatic esters in perfumery | FIRMENICH SA (CH) | 1998-09-29 | — | — | US | claimed |
| JP-10130688-A | — | — | None | — | — | JP | disclosed |
| US-12497577-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor | GIVAUDAN SA (CH) | 2025-12-16 | — | — | US | disclosed |
| US-20240309296-A1 | METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | disclosed |
| US-12024690-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor accord comprising 4-(dodecylthio)-4-methylpentan-2-one | GIVAUDAN SA (CH) | 2024-07-02 | — | — | US | disclosed |
| EP-4338761-A1 | PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | FIRMENICH SA (CH) | 2024-01-02 | — | — | US | disclosed |
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | FIRMENICH SA (CH) | 2024-01-02 | — | — | US | disclosed |
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | FIRMENICH SA (CH) | 2024-01-02 | — | — | US | disclosed |
| EP-3700914-B1 | HYDROGENATION OF CARBONYLS WITH TETRADENTATE PNNP LIGAND RUTHENIUM COMPLEXES | FIRMENICH & CIE (CH) | 2022-02-02 | — | — | EP | disclosed |
| US-20060052277-A1 | Aliphatic compounds as fragrants with musk characteristics | GIVAUDAN SA (CH) | 2006-03-09 | — | — | US | disclosed |
| EP-1565420-A1 | ALIPHATIC COMPOUNDS AS FRAGRANTS WITH MUSK CHARACTERISTICS | Givaudan SA (CH) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004050595-A1 | ALIPHATIC COMPOUNDS AS FRAGRANTS WITH MUSK CHARACTERISTICS | GIVAUDAN SA (CH) | 2004-06-17 | — | — | WO | disclosed |
| US-6717007-B1 | HYDROPHOSPHORYLATION OF OLEFIN WITH HYDROPHOSPHOROUS ACID IN PRESENCE OF INORGANIC PERSULFATE; ANTIMARKONIKOFF ADDITION; LOWER TEMPERATURE AND PRESSURE; MILDER PH | LUPIN LIMITED (IN) | 2004-04-06 | — | — | US | disclosed |
| EP-1218387-B1 | AN IMPROVED REGIOSPECIFIC SYNTHESIS OF PHOSPHONOUS ACIDS | LUPIN LTD (IN) | 2003-05-07 | — | — | EP | disclosed |
| EP-1218387-A1 | AN IMPROVED REGIOSPECIFIC SYNTHESIS OF PHOSPHONOUS ACIDS | Lupin Laboratories Limited (IN) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001019837-A1 | AN IMPROVED REGIOSPECIFIC SYNTHESIS OF PHOSPHONOUS ACIDS | LUPIN LABORATORIES LIMITED (IN) | 2001-03-22 | — | — | WO | disclosed |
| US-5814598-A | Use of unsaturated aliphatic esters in perfumery | FIRMENICH SA (CH) | 1998-09-29 | — | — | US | disclosed |
| JP-H10130688-A | AROMATIZING COMPOSITION, PERFUME PREPARATION, AND METHOD FOR IMPARTING, IMPROVING, INCREASING, OR CHANGING ODOR PROPERTIES OF AROMATIZING COMPOSITION OR PERFUME PREPARATION | FIRMENICH SA | 1998-05-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11858948-B2 | Hydrogenation of carbonyls with tetradentate PNNP ligand ruthenium complexes | ADH1C, ADH1A, ADH5 | GLO1 911/4885ALDH1A1 62/4885LMNA 1023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.